The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.
Allergan and its subsidiaries, Forest Laboratories LLC, Forest Laboratories Inc., and Forest Laboratories Holdings, have reached a settlement of $750 million with a plaintiff class of direct purchasers of Namenda (memantine), a drug to treat...
Mylan Pharmaceuticals is conducting a voluntary nationwide recall in the US of one lot of aprazolam tablets, USP C-IV 0.5 mg, to the consumer level due to the potential presence of foreign substance.
Mylan says the clinical impact from the foreign...
Gilead Sciences and Glympse Bio, a developer of non-invasive technology for disease activity, have entered into a strategic collaboration for nonalcoholic steatohepatitis (NASH) clinical development.
Glympse Bio’s proprietary synthetic biomarkers,...
The UK Department of Transportation has signed freight-capacity contracts to help ensure medicines continue to enter the UK after Brexit. UK Transport Secretary Grant Shapps announced that Brittany Ferries, DFDS, P&O and Stena Line will be...
Teva Pharmaceutical and its affiliates have come to combined $23.3-billion agreements to resolve pending opioid litigation in two Ohio counties and an agreement in principle to settle remaining litigation in other states. The agreement includes $23...
Takeda Pharmaceutical has acquired an exclusive global license, worth up to $420 million, from Chicago-based COUR Pharmaceutical Development Company for developing and commercializing an investigational medicine for treating celiac disease.
The...
As part of its pending $21.4-billion acquisition of GE’s Biopharma business, Danaher Life Sciences, a science and technology company, has agreed to sell select businesses in its life-science platform to Sartorius Stedim Biotech (SSB) for...
Several companies, Sanofi, Dr. Reddy’s Laboratories, and Teva Pharmaceutical, have initiated voluntary recalls of ranitidine products, an anti-acid, due to possible contamination with a nitrosamine impurity, N-nitrosodimethylamine (NDMA).
Sanofi...
GlaxoSmithKline (GSK) is divesting its two vaccines to Bavarian Nordic, a Kvistgaard, Denmark-based company, in a deal worth more than $1 billion.
The two vaccines being divested are Rabavert/Rabipur for preventing rabies and Encepur for...
Ichnos Sciences, a spin-off of Glenmark Holding, has launched as a new, independent biotechnology company focusing on oncology and autoimmune diseases, headquartered in Paramus, New Jersey. The company is in the process of obtaining all the...
The US Food and Drug Administration (FDA) has posted a Warning Letter to Torrent Pharmaceuticals in Ahmedabad, Gujarat, India for several manufacturing violations at its facility in Taluka-Kadi, Indrad, Gujarat, India. Torrent manufactures losartan...
Takeda Pharmaceutical has agreed to divest to Acino, a Zurich-based pharmaceutical company, a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of countries in the Near East, Middle East and Africa...
Novo Nordisk and Bluebird Bio, a developer of gene therapies for severe genetic diseases and cancer, have entered into a three-year research collaboration to jointly develop in vivo genome-editing treatments for genetic diseases, including...
The UK’s Centre for Process Innovation (CPI), the UK government’s process manufacturing arm of Catapult centers that are designed to encourage innovation, has begun work on a project to develop a continuous direct compression (CDC) platform for...
Alexion Pharmaceuticals, a Boston, Massachusetts-based pharmaceutical company focused on rare diseases, has agreed to acquire Achillion Pharmaceuticals, a Blue Bell, Pennsylvania-based clinical-stage biopharmaceutical company focused on developing...
